1
|
Shahzad M, Amin MK, Khalid MF, Basharat A, Noor J, Abbas S, Anwar I, Ud-Din MA, Jaglal M. CLO24-054: Treatment Outcomes in VEXAS Syndrome in Patients With MDS: A Systematic Review. J Natl Compr Canc Netw 2024; 22:CLO24-054. [PMID: 38580244 DOI: 10.6004/jnccn.2023.7173] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/07/2024]
Affiliation(s)
- Moazzam Shahzad
- 1Lee Moffitt Cancer Center, Tampa, FL
- 2University of South Florida, Tampa, FL
| | | | | | | | | | | | - Iqra Anwar
- 3University of Kansas Medical Center, Kansas City, KS
| | | | - Michael Jaglal
- 1Lee Moffitt Cancer Center, Tampa, FL
- 2University of South Florida, Tampa, FL
| |
Collapse
|
2
|
Shahzad M, Noor J, Khalid MF, Amin MK, Nadeem M, Basharat A, Jaglal M. CLO24-091: Outcomes With Sacituzumab Govitecan in Metastatic Breast Cancer: A Systematic Review and Meta-Analysis. J Natl Compr Canc Netw 2024; 22:CLO24-091. [PMID: 38580292 DOI: 10.6004/jnccn.2023.7294] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/07/2024]
Affiliation(s)
- Moazzam Shahzad
- 1H. Lee Moffitt Cancer Center, Tampa, FL
- 2University of South Florida, Tampa, FL
| | | | | | | | | | | | - Michael Jaglal
- 1H. Lee Moffitt Cancer Center, Tampa, FL
- 2University of South Florida, Tampa, FL
| |
Collapse
|
3
|
Shahzad M, Noor J, Khalid MF, Amin MK, Nadeem M, Basharat A, Jaglal M. CLO24-055: Outcomes With Sacituzumab Govitecan in Metastatic Breast Cancer: A Systematic Review and Meta-Analysis. J Natl Compr Canc Netw 2024; 22:CLO24-055. [PMID: 38579835 DOI: 10.6004/jnccn.2023.7295] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/07/2024]
Affiliation(s)
- Moazzam Shahzad
- 1Lee Moffitt Cancer Center, Tampa, FL
- 2University of South Florida, Tampa, FL
| | | | | | | | | | | | - Michael Jaglal
- 1Lee Moffitt Cancer Center, Tampa, FL
- 2University of South Florida, Tampa, FL
| |
Collapse
|
4
|
Shahzad M, Khalid MF, Amin MK, Basharat A, Ammad-Ud-Din M, Park R, Anwar I, Faisal MS, Jaglal M. Geographic and Racial Disparities in Chimeric Antigen Receptor-T Cells and Bispecific Antibodies Trials Access for Diffuse Large B-Cell Lymphoma. Clin Lymphoma Myeloma Leuk 2024:S2152-2650(24)00034-X. [PMID: 38342727 DOI: 10.1016/j.clml.2024.01.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/26/2023] [Revised: 01/09/2024] [Accepted: 01/14/2024] [Indexed: 02/13/2024]
Abstract
BACKGROUND We investigate the geographical and racial disparities in accessing CAR-T and bispecific antibodies trials for DLBCL. MATERIALS AND METHODS ClinicalTrials.gov was searched, and 75 trials with at least 1 open site in the US were included. 2020 US Census Bureau data was used to obtain data on race and ethnicity. SPSS version 26 was used for analysis. RESULTS There were 62 CAR-T and 13 bispecific antibodies trials with 6221 enrolled or expected to enroll patients. Eighty-five percent of the clinical trials were only open in the US, and the majority 64% were pharmaceutical-funded. There were 126 unique study sites distributed over 31 states with 11 (0-51) mean number of trials per state and 4.5 (1-26) and 4.4 (1-24) mean number of CAR-T and bispecific antibodies trials per site, respectively. Southern states had the most number of trials 31%, followed by Midwestern 25%, Northeastern 24%, and Western 20%. The highest number of study locations were in California 13, New York 9, and Pennsylvania 9, while the highest number of open studies were in California 51, Texas 32, and New York 23. Twenty states had no open CAR-T or bispecific antibodies trials. Only 33% of African Americans (AA) lived in a county with a trial, and 7 out of 10 states with the highest proportion of AA residents (18.6%-41.4%) have no or less than 4 trial sites. Of the 62 counties analyzed, 92% were White predominant, while only 8% were AA predominant (P = .009). CONCLUSIONS Strategies should be framed to address the observed disparities and to improve access.
Collapse
Affiliation(s)
- Moazzam Shahzad
- H. Lee Moffitt Cancer Center, Tampa, FL; University of South Florida, Tampa, FL.
| | | | | | | | | | - Robin Park
- H. Lee Moffitt Cancer Center, Tampa, FL; University of South Florida, Tampa, FL
| | - Iqra Anwar
- Kansas University Medical Center, Kansas City, KS
| | | | | |
Collapse
|
5
|
Momanyi BM, Zhou YW, Grace-Mercure BK, Temesgen SA, Basharat A, Ning L, Tang L, Gao H, Lin H, Tang H. SAGESDA: Multi-GraphSAGE networks for predicting SnoRNA-disease associations. Curr Res Struct Biol 2023; 7:100122. [PMID: 38188542 PMCID: PMC10771890 DOI: 10.1016/j.crstbi.2023.100122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2023] [Revised: 11/30/2023] [Accepted: 12/24/2023] [Indexed: 01/09/2024] Open
Abstract
Over the years, extensive research has highlighted the functional roles of small nucleolar RNAs in various biological processes associated with the development of complex human diseases. Therefore, understanding the existing relationships between different snoRNAs and diseases is crucial for advancing disease diagnosis and treatment. However, classical biological experiments for identifying snoRNA-disease associations are expensive and time-consuming. Therefore, there is an urgent need for cost-effective computational techniques that can enhance the efficiency and accuracy of prediction. While several computational models have already been proposed, many suffer from limitations and suboptimal performance. In this study, we introduced a novel Graph Neural Network-based (GNN) classification model, called SAGESDA, which is implemented through the GraphSAGE architecture with attention for the prediction of snoRNA-disease associations. The classifier leverages local neighbouring nodes in a heterogeneous network to generate new node embeddings through message passing. The mini-batch gradient descent technique was applied to divide the graph into smaller sub-graphs, which enhances the model's accuracy, speed and scalability. With these advancements, SAGESDA attained an area under the receiver operating characteristic (ROC) curve (AUC) of 0.92 using the standard dot product classifier, surpassing previous related studies. This notable performance demonstrates that SAGESDA is a promising model for predicting unknown snoRNA-disease associations with high accuracy. The SAGESDA implementation details can be obtained from https://github.com/momanyibiffon/SAGESDA.git.
Collapse
Affiliation(s)
- Biffon Manyura Momanyi
- School of Computer Science and Engineering, Center for Informational Biology, University of Electronic Science and Technology of China, Chengdu, China
| | - Yu-Wei Zhou
- School of Health Care Technology, Chengdu Neusoft University, Chengdu, China
| | - Bakanina Kissanga Grace-Mercure
- School of Life Science and Technology, Center for Informational Biology, University of Electronic Science and Technology of China, Chengdu, 610054, China
| | - Sebu Aboma Temesgen
- School of Life Science and Technology, Center for Informational Biology, University of Electronic Science and Technology of China, Chengdu, 610054, China
| | - Ahmad Basharat
- School of Life Science and Technology, Center for Informational Biology, University of Electronic Science and Technology of China, Chengdu, 610054, China
| | - Lin Ning
- School of Health Care Technology, Chengdu Neusoft University, Chengdu, China
- School of Life Science and Technology, Center for Informational Biology, University of Electronic Science and Technology of China, Chengdu, 610054, China
| | - Lixia Tang
- School of Life Science and Technology, Center for Informational Biology, University of Electronic Science and Technology of China, Chengdu, 610054, China
| | - Hui Gao
- School of Computer Science and Engineering, Center for Informational Biology, University of Electronic Science and Technology of China, Chengdu, China
| | - Hao Lin
- School of Life Science and Technology, Center for Informational Biology, University of Electronic Science and Technology of China, Chengdu, 610054, China
| | - Hua Tang
- School of Basic Medical Sciences, Southwest Medical University, Luzhou, 646000, China
- Basic Medicine Research Innovation Center for Cardiometabolic Diseases, Ministry of Education, Luzhou, 646000, China
- Central Nervous System Drug Key Laboratory of Sichuan Province, Luzhou, 646000, China
| |
Collapse
|
6
|
Ajmal M, Aftab Khan Lodhi F, Nawaz G, Basharat A, Aslam A. Blastomycosis-Induced Acute Respiratory Distress Syndrome. Cureus 2022; 14:e22207. [PMID: 35308721 PMCID: PMC8925978 DOI: 10.7759/cureus.22207] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/13/2022] [Indexed: 11/06/2022] Open
Abstract
Blastomycosis is a systemic mycosis endemic to the Midwestern and South Central United States. Infection is caused by inhaling spores of Blastomyces dermatitidis (B. dermatitidis) that inhabit soil. Acute respiratory distress syndrome (ARDS) is a rare complication of pulmonary blastomycosis with a significantly high mortality rate. We present a case of blastomycosis associated with severe ARDS treated with traditional prone position ventilation (PPV) and neurally adjusted ventilator assist (NAVA) along with antifungal therapy, steroids, and supportive care in a rural setting with no access to extracorporeal membrane oxygenation (ECMO). This case demonstrates that traditional therapies such as prone position ventilation can help patients with blastomycosis-associated ARDS especially in rural settings where advanced therapies such as ECMO are lacking. The use of NAVA in blastomycosis-associated ARDS needs further research.
Collapse
|